These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19656099)

  • 1. [Alcohol septal ablation and prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. A case report].
    Ardashev AV; Shavarov AA; Dzhandzhgava AO; Rybachenko MS; Kriuchko MIu
    Kardiologiia; 2009; 49(6):72-9. PubMed ID: 19656099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic cardiomyopathy in 2013].
    Giannakopoulos G; Frangos C
    Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient?
    Boriani G; Maron BJ; Shen WK; Spirito P
    Circulation; 2004 Oct; 110(15):e438-42. PubMed ID: 15477422
    [No Abstract]   [Full Text] [Related]  

  • 9. Device therapy in hypertrophic cardiomyopathy.
    Beadle R; Williams L
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score.
    Veselka J; Liebregts M; Cooper R; Faber L; Januska J; Kashtanov M; Tesarkova KH; Hansen PR; Seggewiss H; Shloydo E; Popov K; Hansvenclova E; Polakova E; Ten Berg J; Stables RH; Jarkovsky J; Bonaventura J
    Am J Cardiol; 2022 Dec; 184():120-126. PubMed ID: 36192196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management of hypertrophic cardiomyopathy - the most common inherited heart disease].
    Magnusson P; Gadler F; Mörner S
    Lakartidningen; 2018 Jun; 115():. PubMed ID: 29893985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy in children.
    Wang S; Zhu C
    Asian Cardiovasc Thorac Ann; 2022 Jan; 30(1):92-97. PubMed ID: 34569255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
    Veselka J; Zemánek D; Jahnlová D; Krejčí J; Januška J; Dabrowski M; Bartel T; Tomašov P
    Can J Cardiol; 2015 Oct; 31(10):1245-51. PubMed ID: 26095933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiology patient page. Hypertrophic cardiomyopathy: a patient perspective.
    Nishimura RA; Ommen SR; Tajik AJ
    Circulation; 2003 Nov; 108(19):e133-5. PubMed ID: 14609998
    [No Abstract]   [Full Text] [Related]  

  • 18. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory monitoring of aborted sudden cardiac death related to hypertrophic cardiomyopathy.
    Vaglio JC; Sorajja P; Gersh BJ
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):659-62; quiz following 662. PubMed ID: 16306922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
    McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
    Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.